임상시험수탁기관(CRO) 서비스 시장 - 예측(2025-2030년)

The global contract research organization (CRO) service market was estimated at US$ 120.487 billion in 2025 and is expected to grow at a CAGR of 7.79% to attain US$ 175.345 billion by 2030.

The Global Contract Research Organizations Market is experiencing robust growth due to increasing demand for outsourcing services of clinical trials and research activities. The market witnessing the integration of many new emerging technologies such as artificial intelligence, data analytics, and blockchain technology among others. There are strategic collaborations by key market players to expand their capabilities in offering CRO services.

Market Trends:

• Rise in Global Cases of Chronic Diseases: The increasing prevalence of chronic diseases, particularly cancers and diabetes, is a significant factor driving the demand for contract research organization (CRO) services. The growth in chronic disease cases necessitates enhanced drug development efforts, leading to a heightened need for efficient clinical trial services.
• Growing Investment in Research and Development: Key market players are increasing their investments in research and technology, contributing to advancements in the CRO market. Notable examples include:
• In November 2024, AstraZeneca announced an investment of approximately $3.5 billion for research and development, as well as manufacturing new drugs in the USA.
• The incorporation of technologies such as artificial intelligence and data analytics is further enhancing research capabilities.
• North America Market Dynamics:
• North America leads the CRO services market, driven by:
• An advanced healthcare infrastructure.
• The integration of innovative technologies such as artificial intelligence and blockchain.
• In January 2023, RQM+, a prominent regulatory and quality consulting firm, expanded its offerings by introducing comprehensive clinical trial services.
• Asia-Pacific Growth Potential:
• Rapidly growing economies in the Asia-Pacific region, including India, China, and South Korea, are significantly enhancing healthcare infrastructure.
• The availability of a cost-effective and skilled workforce is a critical factor contributing to the growth of CRO services in these countries.
• Conclusion: The rising global incidence of chronic diseases and increasing investments in research and development are shaping the landscape for contract research organizations. As the demand for drug development and clinical trial services continues to grow, both North America and Asia-Pacific are positioned as key regions driving this market's expansion.

Some of the major players covered in this report include PPD Inc. (Thermo Fisher Scientific Inc.), IQVIA Inc, ICON plc, Paraxel International Corporation, NAMSA, Labcorp Drug Development, WuXi AppTec, Syneos Health, Evotec SE, Novotech, CliniExperts, PharPoint, Veranex among others.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Global Contract Research Organizations Market is analyzed into the following segments:

By Molecular Type

• Vaccines
• Cell Gene Therapy
• Others

By Type

• Early Phase Development Services
• Clinical Research Services
• Laboratory Services
• Consulting Services

By Therapeutic Area

• Oncology
• CNS Disorders
• Other Therapeutic Areas

By End-User

• Pharmaceuticals and Biopharmaceuticals Companies
• Medical Devices Companies
• Academic Institutes

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• Japan
• India
• South Korea
• Taiwan
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Processes

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. CXO Perspective

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. CONTRACT RESEARCH ORGANIZATIONS MARKET (CRO) SERVICES BY MOLECULAR TYPE

• 5.1. Introduction
• 5.2. Vaccines
• 5.3. Cell Gene Therapy
• 5.4. Others

6. CONTRACT RESEARCH ORGANIZATIONS (CRO) SERVICES MARKET BY TYPE

• 6.1. Introduction
• 6.2. Early Phase Development Services
  • 6.2.1. Preclinical
  • 6.2.2. Toxicology Testing
  • 6.2.3. Discovery Studies
  • 6.2.4. Chemistry, Manufacturing, and Controls
  • 6.2.5. Pharmacokinetics /Pharmacodynamics
• 6.3. Clinical Research Services
  • 6.3.1. Phase I
  • 6.3.2. Phase II
  • 6.3.3. Phase III
  • 6.3.4. Phase IV
  • 6.3.5. Phase V
• 6.4. Laboratory Services

6.4.1. Analytical Testing

• 6.4.2. Bioanalytical Testing
• 6.4.3. Physical Characterization
• 6.4.4. Stability Testing, Batch Release Testing
• 6.4.5. Raw Material Testing
• 6.4.6. Other Analytical Testing
• 6.5. Consulting Services

7. CONTRACT RESEARCH ORGANIZATIONS (CRO) SERVICES MARKET BY THERAPEUTIC AREA

• 7.1. Introduction
• 7.2. Oncology
  • 7.2.1. Breast Cancer
  • 7.2.2. Lung Cancer
  • 7.2.3. Colorectal Cancer
  • 7.2.4. Prostate Cancer
  • 7.2.5. Others
• 7.3. CNS Disorders
  • 7.3.1. Infectious Diseases
  • 7.3.2. Cardiovascular Diseases
  • 7.3.3. Respiratory Disorders
  • 7.3.4. Diabetes
• 7.4. Other Therapeutic Areas

8. CONTRACT RESEARCH ORGANIZATIONS (CRO) SERVICES MARKET BY END-USER

• 8.1. Introduction
• 8.2. Pharmaceuticals and Biopharmaceuticals Companies
• 8.3. Medical Devices Companies
• 8.4. Academic Institutes

9. CONTRACT RESEARCH ORGANIZATIONS (CRO) SERVICES MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. By Molecular Type
  • 9.2.2. By Type
  • 9.2.3. By Therapeutic Area
  • 9.2.4. By End-User
  • 9.2.5. By Country
    • 9.2.5.1. USA
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. South America
  • 9.3.1. By Molecular Type
  • 9.3.2. By Type
  • 9.3.3. By Therapeutic Area
  • 9.3.4. By End-User
  • 9.3.5. By Country
    • 9.3.5.1. Brazil
    • 9.3.5.2. Argentina
    • 9.3.5.3. Others
• 9.4. Europe
  • 9.4.1. By Molecular Type
  • 9.4.2. By Type
  • 9.4.3. By Therapeutic Area
  • 9.4.4. By End-User
  • 9.4.5. By Country
    • 9.4.5.1. United Kingdom
    • 9.4.5.2. Germany
    • 9.4.5.3. France
    • 9.4.5.4. Spain
    • 9.4.5.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. By Molecular Type
  • 9.5.2. By Type
  • 9.5.3. By Therapeutic Area
  • 9.5.4. By End-User
  • 9.5.5. By Country
    • 9.5.5.1. Saudi Arabia
    • 9.5.5.2. UAE
    • 9.5.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. By Molecular Type
  • 9.6.2. By Type
  • 9.6.3. By Therapeutic Area
  • 9.6.4. By End-User
  • 9.6.5. By Country
    • 9.6.5.1. China
    • 9.6.5.2. Japan
    • 9.6.5.3. South Korea
    • 9.6.5.4. Australia
    • 9.6.5.5. India
    • 9.6.5.6. Indonesia
    • 9.6.5.7. Thailand
    • 9.6.5.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. PPD Inc. (Thermo Fisher Scientific Inc)
• 11.2. IQVIA Inc
• 11.3. ICON Plc
• 11.4. Parexel International Corporation
• 11.5. NAMSA
• 11.6. Labcorp Drug Development
• 11.7. WuXi AppTec
• 11.8. Syneos Health
• 11.9. Evotec SE
• 11.10. Novotech
• 11.11. CliniExperts
• 11.12. PharPoint
• 11.13. Veranex